Cost of weight-loss drug Mounjaro could rise significantly
The cost of the weight-loss drug Mounjaro is set to rise significantly in the UK. The recommended price for the drug is expected to increase by up to 170%, according to reports. Mounjaro, also known as tirzepatide, is a relatively new medication that has been shown to be effective in helping people lose weight. The price hike is likely to have an impact on the healthcare system and patients who require the drug. However, the full extent of the impact on consumers is not yet clear. It is possible that the increase in price may be mitigated by changes in insurance coverage or other factors. Overall, the news of the price increase for Mounjaro is likely to be of concern to those who rely on the drug for weight management. It remains to be seen how this will affect the accessibility and affordability of the medication in the UK.
Note: This is an AI-generated summary of the original article. For the full story, please visit the source link below.
